These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 19941109)
1. Pharmacological modification of dendritic cells to promote their tolerogenicity in transplantation. Turnquist HR; Fischer RT; Thomson AW Methods Mol Biol; 2010; 595():135-48. PubMed ID: 19941109 [TBL] [Abstract][Full Text] [Related]
2. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116 [TBL] [Abstract][Full Text] [Related]
3. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression. Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629 [TBL] [Abstract][Full Text] [Related]
4. Use of rapamycin in the induction of tolerogenic dendritic cells. Fischer R; Turnquist HR; Taner T; Thomson AW Handb Exp Pharmacol; 2009; (188):215-32. PubMed ID: 19031028 [TBL] [Abstract][Full Text] [Related]
5. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751 [TBL] [Abstract][Full Text] [Related]
7. Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation. Turnquist HR; Thomson AW Curr Opin Organ Transplant; 2008 Aug; 13(4):350-7. PubMed ID: 18685329 [TBL] [Abstract][Full Text] [Related]
8. Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation. Liu Y; Chen Y; Liu FQ; Lamb JR; Tam PK Transpl Int; 2008 May; 21(5):483-94. PubMed ID: 18266776 [TBL] [Abstract][Full Text] [Related]
9. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783 [TBL] [Abstract][Full Text] [Related]
10. Rapamycin-conditioned dendritic cells activated with monophosphoryl lipid-A promote allograft acceptance in vivo. Campos-Acuña J; Pérez F; Narváez E; Campos-Mora M; Gajardo T; Catalán D; Aguillón JC; Pino-Lagos K Immunotherapy; 2015; 7(2):101-10. PubMed ID: 25713986 [TBL] [Abstract][Full Text] [Related]
11. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation. Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689 [TBL] [Abstract][Full Text] [Related]
12. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841 [TBL] [Abstract][Full Text] [Related]
13. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus. Tao R; Wang L; Chen CH; Wang SH; Demarco RA; Lotze MT; Thai NL; Fung JJ; Lu L; Qian S J Heart Lung Transplant; 2006 Mar; 25(3):310-9. PubMed ID: 16507425 [TBL] [Abstract][Full Text] [Related]
14. Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction. Fedoric B; Krishnan R Immunol Lett; 2008 Oct; 120(1-2):49-56. PubMed ID: 18652845 [TBL] [Abstract][Full Text] [Related]
15. Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A. Ko H; Hambly BD; Eris JM; Levidiotis V; Wyburn K; Wu H; Chadban SJ; Yin JL Transpl Immunol; 2008 Nov; 20(1-2):99-105. PubMed ID: 18662782 [TBL] [Abstract][Full Text] [Related]
16. Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs. van Kooten C; Stax AS; Woltman AM; Gelderman KA Handb Exp Pharmacol; 2009; (188):233-49. PubMed ID: 19031029 [TBL] [Abstract][Full Text] [Related]
17. [Rapamycin combined with donor bone marrow-derived immature dendritic cells induces mouse skin allograft tolerance]. Yu S; He X; Hu A; Fu BM; Ma Y Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):399-402. PubMed ID: 18359700 [TBL] [Abstract][Full Text] [Related]
18. Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Adorini L; Penna G Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030 [TBL] [Abstract][Full Text] [Related]
19. Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance. Li M; Zhang X; Zheng X; Lian D; Zhang ZX; Sun H; Suzuki M; Vladau C; Huang X; Xia X; Zhong R; Garcia B; Min WP Int Immunol; 2008 Feb; 20(2):285-93. PubMed ID: 18182381 [TBL] [Abstract][Full Text] [Related]
20. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network. Bodey B; Bodey B; Kaiser HE In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]